The US is planning to pursue a robust trade agenda in 2013.  There currently is a spirited debate regarding the inclusion of biologics in the free trade agreement (FTA) the US is negotiating with the Asia-Pacific region, the Trans- Pacific Partnership (TPP). Additionally, the US and the EU have recently announced a new trade agreement that will strengthen the economic ties between Europe and the United States. This panel will provide different perspectives on the benefits of trade as well as the opportunities and challenges presented by the inclusion of biologics in contemporary trade agreements. 

Learning Objectives:

• Share the patient and scientist perspectives on biologics and trade
• Highlight the potential impact of trade agreements on economies and health systems
• Examine US trade policy going forward

Ability Level: All

Session ID: 1926